Cabozantinib with nivolumab for untreated advanced renal cell carcinoma

Register of interests (PDF 287 KB)

Final draft guidance

Final draft guidance (PDF 197 KB)

Final draft guidance Pathways (PDF 640 KB)

Committee papers (PDF 6.81 MB)

Public committee slides (PDF 796 KB)

Equality impact assessment (PDF 164 KB)

Assessment report (PDF 7.63 MB)

Assessment report Final Analysis Plan (PDF 1.2 MB)

Assessment report plain English summary (PDF 170 KB)

Draft guidance

Appraisal consultation document (online commenting) • Pathways Model Report

Draft guidance (PDF version) Pathways Model Report (PDF 638 KB)

Appraisal consultation document (online commenting) Draft Guidance on treating cabozantinib with nivolumab 

Appraisal consultation document (PDF version) Draft Guidance on treating cabozantinib with nivolumab  (PDF 249 KB)

Committee papers (PDF 16.99 MB)

Public committee slides (PDF 3.82 MB)

Final scope (PDF 273 KB)

Final stakeholder list (PDF 175 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 403 KB)

Statement PATT pathways process statement (PDF 154 KB)

Draft scope post referral (PDF 305 KB)

Draft matrix post referral (PDF 165 KB)